MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 25861-25870 Newer>
The Motley Fool
August 31, 2007
Toby Shute
The Delisting Debacle Many global firms are leaving the NYSE; trading volume of these issues is very light relative to activity back on home exchanges, so the companies figure the cost of Sarbanes-Oxley compliance outweighs the benefit of the U.S. listing. mark for My Articles 38 similar articles
The Motley Fool
August 31, 2007
Ryan Fuhrmann
Option Weighs Down H&R Block H&R Block's misguided venture into the subprime mortgage business cost the company almost $1 billion last year, and selling off the unit is proving difficult. mark for My Articles 515 similar articles
The Motley Fool
August 31, 2007
Jeremy MacNealy
Inventory Bogs Down Citi Trends Sales remain strong at urban retailer Citi Trends, but despite management efforts, inventory is 40% higher than last year, negatively affecting earnings in the second quarter. mark for My Articles 808 similar articles
The Motley Fool
August 31, 2007
Mike Cianciolo
Cost Plus Adds Losses: Fool by Numbers Home-furnishings retailer Cost Plus's second quarter reports show a sharp decline in comps, although management remains confident about the company's turnaround strategy. mark for My Articles 1959 similar articles
The Motley Fool
August 31, 2007
Dialing for dELiA*s: Fool by Numbers The fast facts about fashion retailer dELiA*s quarterly results show increased revenue, increased sales, increased comps, but alas, decreased margins. mark for My Articles 2062 similar articles
The Motley Fool
August 31, 2007
Mike Cianciolo
Wake Up, Cost Plus The home furnishings retailer reports increased losses and projects more in the third quarter. mark for My Articles 213 similar articles
The Motley Fool
August 31, 2007
Brian Lawler
4 Biotech Bets Under $10 Development stage drugmakers are among the most exciting stocks to follow. Here are four that are all worth a place on your watch list: Pharmacopeia, Pain Therapeutics, Pharmasset, and SGX Pharmaceuticals. mark for My Articles 252 similar articles
The Motley Fool
August 31, 2007
Rick Aristotle Munarriz
Amazon.com Cranks Up the Music Amazon, the country's leading online retailer, will launch its eagerly anticipated MP3 store in three weeks. The company will be selling songs in the MP3 format, free of digital rights management. Will it take a bite out of Apple? mark for My Articles 1344 similar articles
The Motley Fool
August 31, 2007
Tom Taulli
Mr. Softy Gets Chatty Software giant Microsoft acquires Parlano, to further its efforts to streamline unified communications. mark for My Articles 162 similar articles
The Motley Fool
August 31, 2007
Tom Taulli
Symantec Goes to M&A Rehab The security software giant says it will forgo mega-deals. Rather, the focus will be on smaller deals, such as its $970 million purchase of Altiris in April. The new strategy should be good news for shareholders. mark for My Articles 151 similar articles
<Older 25861-25870 Newer>    Return to current articles.